PRECISION BIOSCIENCES INC Financing Cash Flow
PRECISION BIOSCIENCES INC (DTIL) reported Financing Cash Flow of $745.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $745.00K, a 93.03% decline year-over-year.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $77.52M, a 1209.39% increase year-over-year.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.66M, a 55.56% decline year-over-year.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for fiscal 2025 was $95.16M, a 88.63% increase from fiscal 2024.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for fiscal 2024 was $50.45M, a 836.51% increase from fiscal 2023.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for fiscal 2023 was $5.39M, a 94.33% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC net cash provided by (used in) financing activities for fiscal 2022 was $94.98M, a 34.69% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $745.00K 10-Q · filed 2026-08-06 | $78.26M derived: sum of 3 quarters · filed 2026-08-06 | $79.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $745.00K 10-Q · filed 2026-05-05 | $78.26M derived: sum of 2 quarters · filed 2026-05-05 | $79.92M derived: sum of 3 quarters · filed 2026-05-05 | $85.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $77.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $79.17M derived: sum of 2 quarters · filed 2026-03-12 | $84.47M derived: sum of 3 quarters · filed 2026-08-06 | $95.16M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $6.96M derived: sum of 2 quarters · filed 2026-08-06 | $17.65M 10-Q · filed 2025-11-03 | $23.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.99M 10-Q · filed 2026-08-06 | $21.91M derived: sum of 3 quarters · filed 2026-08-06 | $25.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.69M 10-Q · filed 2026-05-05 | $16.61M derived: sum of 2 quarters · filed 2026-05-05 | $20.34M derived: sum of 3 quarters · filed 2026-05-05 | $21.04M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.65M derived: sum of 2 quarters · filed 2026-03-12 | $10.36M derived: sum of 3 quarters · filed 2026-03-12 | $50.45M 10-K · filed 2026-03-12 |
| 2024-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $4.43M derived: sum of 2 quarters · filed 2025-11-03 | $44.53M 10-Q · filed 2025-11-03 | $47.36M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $702.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $40.80M 10-Q · filed 2025-08-07 | $43.63M derived: sum of 3 quarters · filed 2025-08-07 | $43.59M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $40.09M 10-Q · filed 2025-05-15 | $42.92M derived: sum of 2 quarters · filed 2025-05-15 | $42.89M derived: sum of 3 quarters · filed 2025-05-15 | $44.74M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.79M derived: sum of 2 quarters · filed 2025-03-26 | $4.65M derived: sum of 3 quarters · filed 2025-03-26 | $5.39M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.82M derived: sum of 2 quarters · filed 2024-11-04 | $2.56M 10-Q · filed 2024-11-04 | $2.56M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.59M 10-Q · filed 2024-08-01 | $2.59M derived: sum of 3 quarters · filed 2024-08-01 | $2.41M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $741.00K 10-Q · filed 2024-05-13 | $741.00K derived: sum of 2 quarters · filed 2024-05-13 | $561.00K derived: sum of 3 quarters · filed 2024-05-13 | $93.48M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$180.00K derived: sum of 2 quarters · filed 2024-03-27 | $92.74M derived: sum of 3 quarters · filed 2024-03-27 | $94.98M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $92.74M derived: sum of 2 quarters · filed 2023-11-07 | $94.98M 10-Q · filed 2023-11-07 | $103.36M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $92.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $95.17M 10-Q · filed 2023-08-04 | $103.54M derived: sum of 3 quarters · filed 2023-08-04 | $115.46M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-09 | $10.63M derived: sum of 2 quarters · filed 2023-05-09 | $22.54M derived: sum of 3 quarters · filed 2023-05-09 | $36.05M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $20.29M derived: sum of 2 quarters · filed 2023-03-09 | $33.81M derived: sum of 3 quarters · filed 2023-03-09 | $70.52M 10-K · filed 2023-03-09 |
| 2021-09-30 | $11.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $25.43M derived: sum of 2 quarters · filed 2022-11-08 | $62.14M 10-Q · filed 2022-11-08 | $62.34M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $13.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $50.23M 10-Q · filed 2022-08-08 | $50.42M derived: sum of 3 quarters · filed 2022-08-08 | $50.96M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $36.72M 10-Q · filed 2022-05-09 | $36.91M derived: sum of 2 quarters · filed 2022-05-09 | $37.45M derived: sum of 3 quarters · filed 2022-05-09 | $37.73M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $730.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.01M derived: sum of 3 quarters · filed 2022-03-15 | $1.33M 10-K · filed 2022-03-15 |
| 2020-09-30 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $817.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.13M 10-Q · filed 2021-11-10 | $1.84M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $599.00K 10-Q · filed 2021-08-12 | $1.30M derived: sum of 3 quarters · filed 2021-08-12 | $1.37M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $314.00K 10-Q · filed 2021-05-13 | $1.02M derived: sum of 2 quarters · filed 2021-05-13 | $1.08M derived: sum of 3 quarters · filed 2021-05-13 | $135.39M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $767.00K derived: sum of 2 quarters · filed 2021-03-18 | $135.08M derived: sum of 3 quarters · filed 2021-03-18 | $173.37M 10-K · filed 2021-03-18 |
| 2019-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $134.37M derived: sum of 2 quarters · filed 2020-11-10 | $172.67M 10-Q · filed 2020-11-10 | $171.08M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $134.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $172.61M 10-Q · filed 2020-08-13 | $171.01M derived: sum of 3 quarters · filed 2020-08-13 | $192.33M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $38.30M 10-Q · filed 2020-05-15 | $36.70M derived: sum of 2 quarters · filed 2020-05-15 | $58.02M derived: sum of 3 quarters · filed 2020-05-15 | $146.05M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $19.73M derived: sum of 2 quarters · filed 2020-03-10 | $107.76M derived: sum of 3 quarters · filed 2020-03-10 | $107.78M 10-K · filed 2020-03-10 |
| 2018-09-30 | $21.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $109.35M derived: sum of 2 quarters · filed 2019-11-12 | $109.37M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $88.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $88.05M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $20.00K 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |